FORBES
Packaging cancer
About RS Research
This author has not written his bio yet.
But we are proud to say that RS Research contributed 66 entries already.
Entries by RS Research
DUNYA
Investments in start-up ecosystem
HABERTURK
Unicorn of healthcare will be born in Boğaziçi University
DUNYA
Accelerated technology transfer: our global projects gain speed
Major investment in Turkish biotechnology start-up
Technology focused venture capital fund ACT Venture Partners, whose main investor is European Investment Fund, has invested 1.1 million Euros in nanomedicine start-up RS Research. The company began developing drug candidates with improved efficacy and reduced side effect […]
Bİyoteknolojİ alanında büyük yatırım
Teknoloji ticarileştirme odaklı risk sermayesi fonu ACT Venture Partners Teknopark İstanbul’da kurulan sağlık girişimi RS Research’e 1,1 milyon Euro yatırım yaptı. […]
RS Research is a clinically-validated biotech company developing targeted oncology therapies using Sagitta® drug-delivery platforms, disrupting the efficacy-toxicity trade-off.
